# RCT of Fomitopsis Officinalis and Trametes Versicolor to Treat COVID-19

> **NCT04667247** · PHASE1,PHASE2 · COMPLETED · sponsor: **Gordon Saxe** · enrollment: 54 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** FoTv

## Key facts

- **NCT ID:** NCT04667247
- **Lead sponsor:** Gordon Saxe
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-23
- **Primary completion:** 2022-03-21
- **Final completion:** 2022-05-04
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2025-08-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04667247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04667247, "RCT of Fomitopsis Officinalis and Trametes Versicolor to Treat COVID-19". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04667247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*